BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Omeros Corporation Announces Upcoming Presentations Detailing Outcomes of Narsoplimab Treatment for TA-TMA Under an Expanded Access Program

  February 10, 2025

   · 

  7 min read
• Press Releases

  GE HealthCare management to present at upcoming investor conference

  February 10, 2025

   · 

  1 min read
• Press Releases

  LIB Therapeutics Announces FDA Acceptance of Biologics License Application for Lerodalcibep to Lower LDL-Cholesterol Across Broad Patient Population

  February 10, 2025

   · 

  4 min read
• Press Releases

  IgGenix to Present Alpha-gal Syndrome Monoclonal Antibody Discovery at 2025 AAAAI / WAO Joint Congress

  February 10, 2025

   · 

  2 min read
• Press Releases

  Immix Biopharma Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for NXC-201, sterically-optimized CAR-T for relapsed/refractory AL Amyloidosis

  February 10, 2025

   · 

  7 min read
• Press Releases

  DNA Sequencing Market Size Leads by 21.69% Healthy CAGR to Hit $107.63 Billion by 203

  February 10, 2025

   · 

  1 min read
• Press Releases

  Arcus Biosciences to Present New Data from Casdatifan, a HIF-2a Inhibitor, in an Oral Presentation at the 2025 ASCO GU Symposium

  February 10, 2025

   · 

  6 min read
• Press Releases

  Onco-Innovations’ Licensed PNKP Inhibitor Technology Shown to Increase Sensitivity of Cancer Cells to Radiation in Animal Study

  February 10, 2025

   · 

  7 min read
• Press Releases

  Pfizer and Astellas’ PADCEV® (enfortumab vedotin-ejfv) plus KEYTRUDA® (pembrolizumab) Shows Long-Term Efficacy in First-Line Treatment of Locally Advanced or Metastatic Urothelial Cancer (la/mUC)

  February 10, 2025

   · 

  19 min read
• Press Releases

  Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 10, 2025

  February 10, 2025

   · 

  3 min read